Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by
Crossref.
Burton, P.B.J.
Raff, M.C.
Kerr, P.
Yacoub, M.H.
and
Barton, P.J.R.
1999.
An Intrinsic Timer That Controls Cell-Cycle Withdrawal in Cultured Cardiac Myocytes.
Developmental Biology,
Vol. 216,
Issue. 2,
p.
659.
Schultz, Jo El J.
Witt, Sandra A.
Nieman, Michelle L.
Reiser, Peter J.
Engle, Sandra J.
Zhou, Ming
Pawlowski, Sharon A.
Lorenz, John N.
Kimball, Thomas R.
and
Doetschman, Thomas
1999.
Fibroblast growth factor-2 mediates pressure-induced hypertrophic response.
Journal of Clinical Investigation,
Vol. 104,
Issue. 6,
p.
709.
Molkentin, Jeffery D
and
Dorn II, Gerald W
2001.
Cytoplasmic Signaling Pathways That Regulate Cardiac Hypertrophy.
Annual Review of Physiology,
Vol. 63,
Issue. 1,
p.
391.
Scheinowitz, M.
Kessler-Icekson, G.
Freimann, S.
Zimmermann, R.
Schaper, W.
Golomb, E.
Savion, N.
and
Eldar, M.
2003.
Short- and long-term swimming exercise training increases myocardial insulin-like growth factor-I gene expression.
Growth Hormone & IGF Research,
Vol. 13,
Issue. 1,
p.
19.
Nishida, Masahiko
Li, Tao-Sheng
Hirata, Ken
Yano, Masafumi
Matsuzaki, Masunori
and
Hamano, Kimikazu
2003.
Improvement of cardiac function by bone marrow cell implantation in a rat hypoperfusion heart model.
The Annals of Thoracic Surgery,
Vol. 75,
Issue. 3,
p.
768.
Freimann, Sarit
Scheinowitz, Mickey
Yekutieli, Daniel
Feinberg, Micha S.
Eldar, Michael
and
Kessler-Icekson, Gania
2005.
Prior exercise training improves the outcome of acute myocardial infarction in the rat.
Journal of the American College of Cardiology,
Vol. 45,
Issue. 6,
p.
931.
Virag, Jitka A.I.
Rolle, Marsha L.
Reece, Julia
Hardouin, Sandrine
Feigl, Eric O.
and
Murry, Charles E.
2007.
Fibroblast Growth Factor-2 Regulates Myocardial Infarct Repair.
The American Journal of Pathology,
Vol. 171,
Issue. 5,
p.
1431.
Scott, Robert C
Crabbe, Deborah
Krynska, Barbara
Ansari, Ramin
and
Kiani, Mohammad F
2008.
Aiming for the heart: targeted delivery of drugs to diseased cardiac tissue.
Expert Opinion on Drug Delivery,
Vol. 5,
Issue. 4,
p.
459.
Gutiérrez, Orlando M.
Januzzi, James L.
Isakova, Tamara
Laliberte, Karen
Smith, Kelsey
Collerone, Gina
Sarwar, Ammar
Hoffmann, Udo
Coglianese, Erin
Christenson, Robert
Wang, Thomas J.
deFilippi, Christopher
and
Wolf, Myles
2009.
Fibroblast Growth Factor 23 and Left Ventricular Hypertrophy in Chronic Kidney Disease.
Circulation,
Vol. 119,
Issue. 19,
p.
2545.
Wolf, Myles
2010.
Forging Forward with 10 Burning Questions on FGF23 in Kidney Disease.
Journal of the American Society of Nephrology,
Vol. 21,
Issue. 9,
p.
1427.
Gutiérrez, Orlando M.
2010.
Fibroblast Growth Factor 23 and Disordered Vitamin D Metabolism in Chronic Kidney Disease.
Clinical Journal of the American Society of Nephrology,
Vol. 5,
Issue. 9,
p.
1710.
Faul, Christian
Amaral, Ansel P.
Oskouei, Behzad
Hu, Ming-Chang
Sloan, Alexis
Isakova, Tamara
Gutiérrez, Orlando M.
Aguillon-Prada, Robier
Lincoln, Joy
Hare, Joshua M.
Mundel, Peter
Morales, Azorides
Scialla, Julia
Fischer, Michael
Soliman, Elsayed Z.
Chen, Jing
Go, Alan S.
Rosas, Sylvia E.
Nessel, Lisa
Townsend, Raymond R.
Feldman, Harold I.
St. John Sutton, Martin
Ojo, Akinlolu
Gadegbeku, Crystal
Di Marco, Giovana Seno
Reuter, Stefan
Kentrup, Dominik
Tiemann, Klaus
Brand, Marcus
Hill, Joseph A.
Moe, Orson W.
Kuro-o, Makoto
Kusek, John W.
Keane, Martin G.
and
Wolf, Myles
2011.
FGF23 induces left ventricular hypertrophy.
Journal of Clinical Investigation,
Vol. 121,
Issue. 11,
p.
4393.
Shalhoub, Victoria
Shatzen, Edward M.
Ward, Sabrina C.
Davis, James
Stevens, Jennitte
Bi, Vivian
Renshaw, Lisa
Hawkins, Nessa
Wang, Wei
Chen, Ching
Tsai, Mei-Mei
Cattley, Russell C.
Wronski, Thomas J.
Xia, Xuechen
Li, Xiaodong
Henley, Charles
Eschenberg, Michael
and
Richards, William G.
2012.
FGF23 neutralization improves chronic kidney disease–associated hyperparathyroidism yet increases mortality.
Journal of Clinical Investigation,
Vol. 122,
Issue. 7,
p.
2543.
Faul, Christian
2012.
Fibroblast growth factor 23 and the heart.
Current Opinion in Nephrology and Hypertension,
Vol. 21,
Issue. 4,
p.
369.
Negri, Armando Luis
2014.
Fibroblast growth factor 23: associations with cardiovascular disease and mortality in chronic kidney disease.
International Urology and Nephrology,
Vol. 46,
Issue. 1,
p.
9.
Wolf, Myles
2015.
Mineral (Mal)Adaptation to Kidney Disease—Young Investigator Award Address.
Clinical Journal of the American Society of Nephrology,
Vol. 10,
Issue. 10,
p.
1875.
Domouzoglou, Eleni M.
Naka, Katerina K.
Vlahos, Antonios P.
Papafaklis, Michail I.
Michalis, Lampros K.
Tsatsoulis, Agathoklis
and
Maratos-Flier, Eleftheria
2015.
Fibroblast growth factors in cardiovascular disease: The emerging role of FGF21.
American Journal of Physiology-Heart and Circulatory Physiology,
Vol. 309,
Issue. 6,
p.
H1029.
2017.
FGF-23 and Left Ventricular Hypertrophy.
Journal of Cardiology & Current Research,
Vol. 9,
Issue. 3,
Faul, Christian
2017.
Cardiac actions of fibroblast growth factor 23.
Bone,
Vol. 100,
Issue. ,
p.
69.
Liu, Eva S
Thoonen, Robrecht
Petit, Elizabeth
Yu, Binglan
Buys, Emmanuel S
Scherrer-Crosbie, Marielle
and
Demay, Marie B
2018.
Increased Circulating FGF23 Does Not Lead to Cardiac Hypertrophy in the Male Hyp Mouse Model of XLH.
Endocrinology,
Vol. 159,
Issue. 5,
p.
2165.